XML 51 R25.htm IDEA: XBRL DOCUMENT

Other Financial Statement Information (Tables)

12 Months Ended

Dec. 31, 2024

Other Financial Statement Information [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):


		December 31,
		2024				2023
Interest income receivable		$	3,773			$	512
Prepaid clinical trial costs			2,228				5,273
Prepaid commercial planning costs			933				789
Prepaid insurance			709				597
Prepaid software costs			660				237
Prepaid professional services fees			659				198
Prepaid medical affairs costs			246				—
Prepaid rent			224				257
Prepaid drug manufacturing costs			21				1,207
Other			913				2,237
Total prepaid expenses and other current assets		$	10,366			$	11,307

Schedule of Accrued Expenses And Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


		December 31,
		2024				2023
Accrued payroll		$	6,822			$	3,932
Accrued clinical and drug manufacturing expenses			6,742				2,213
Accrued commercial expenses			689				19
Accrued information technology expenses			455				37
Accrued legal fees			257				59
Related party payable			217				1,926
Other accrued expenses and current liabilities			1,041				563
Total accrued expenses and other current liabilities		$	16,223			$	8,749